IL-33 is related to pathogenic mechanisms in neurodegenerative disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), multiple sclerosis (MS), Huntington’s disease (HD), chronic traumatic encephalopathy (CTE), and amyotrophic lateral sclerosis (ALS). This evidence concerns the gene IL33 and Parkinson disease.